Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-12-16

FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application to add PREVACID SOLUTAB (lansoprazole) as a soluble tablet formulation. This expands the approved dosage forms for l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREVACID SOLUTAB (LANSOPRAZOLE)

Snippet

SUPPL AP for PREVACID SOLUTAB (LANSOPRAZOLE)